Collaboration, partnership, and clinical integration are key.

Dublin, Jan. 30, 2026 (GLOBE NEWSWIRE) -- The "Precision Diagnostics Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2021-2031" has been added to ResearchAndMarkets.com's ...

Tau protein aggregation is a shared feature in over 20 neurodegenerative diseases (collectively referred to as "tauopathies"). New research led by Boston Children's Hospital challenges the current ...

Halo Precision Diagnostics planned in the Onicx Group medical office building at Seven Pines at southwest Butler Boulevard and Interstate 95. The city issued a permit Feb. 13 for the $4.1 million ...

Physician-led Advanced Therapeutic Plasma Exchange (TPE) protocols launch inside Cenegenics Beverly Hills, expanding access to personalized toxin reduction and biomarker-driven care in Southern ...

Tempus AI recently reported clinical validation results showing its Immune Profile Score (IPS) more accurately predicts outcomes for patients on immune checkpoint inhibitors than conventional ...

Insight Molecular Diagnostics Inc. operates as a precision diagnostics company in the United States and internationally. The company develops and commercializes laboratory developed tests, kitted ...

CRISPR gene editing and next-generation sequencing (NGS) have transformed clinical and life sciences research. CRISPR permits the selective targeting and editing of specific nucleotide sequences, with ...

The COVID-19 pandemic forced a number of changes, many of which will remain in place long after it subsides. One important but under-recognized shift could be in the field of clinical diagnostics.

Very polite and great customer service. I would give a 5 but that is all the check in automated service. It prompted me to wait out in my car and get a text. I made an appointment for 7 mins ahead for ...

4 College of Medical and Dental Sciences, Institute of Cancer and Genomic Sciences, Centre for Computational Biology, University of Birmingham, Birmingham, UK 5 Institute of Translational Medicine, ...

The driving force behind the lab was a desire to control biomarker discovery, streamline regulatory approvals for CDx, and develop drugs more cheaply and quickly.